Journal of cardiovascular medicine (Hagerstown, Md.) · 2026
The impact of sex and its interaction with temporary mechanical circulatory support in cardiogenic shock patients.
СтатьяМногоцентровое исследованиеНаблюдательное исследованиеСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bertaina Maurizio, Iannaccone Mario, Sorini Dini Carlotta, Frea Simone, Bernasconi Davide Paolo, Viola Giovanna, Briani Martina, Pagnesi Matteo, Potena Luciano, Colombo Costanza Natalia Julia, De Ferrari Gaetano Maria, Marini Marco, Maj Giulia, Tavazzi Guido, Morici Nuccia, Valente Serafina, Oliva Fabrizio, Pappalardo Federico, Sacco Alice, Altshock-2 Registry Investigators
Аннотация
BACKGROUND: Temporary mechanical circulatory support (tMCS) is increasingly used in managing cardiogenic shock, yet women remain underrepresented in studies evaluating its role. This analysis aims to clarify sex-specific in-hospital outcomes among cardiogenic shock patients treated with and without tMCS.
METHODS: We analyzed consecutive cardiogenic shock patients enrolled from January 2020 to November 2023 in the multicenter Altshock-2 Registry. The primary outcome was in-hospital mortality.
RESULTS: Among 692 patients [162 (23%) women, 530 (77%) men, mean age 65 (SD 14) years], cardiogenic shock was due to myocardial infarction in 50.1% and heart failure in 29.1%. Other causes were more common in females vs. males (30.5 vs. 17.8%, P value 0.03). At presentation, women had higher lactate levels [3.4 (1.7-7.3) vs. 2.6 (1.6-5.3) mmol/l, P value 0.03] and more frequent severe right ventricular dysfunction (61.8 vs. 49.6%, P value 0.02). tMCS was used in 445 (64.7%) patients without significant sex differences (P value 0.5). Intra-aortic balloon pump was the most used device (73% women vs. 82% men, P value 0.06), followed by extra corporeal membrane oxygenation (33.7 vs. 29.7%, P value 0.4) and Impella (18.8 vs. 23.5%, P value 0.3). A not-significant higher in-hospital mortality in women emerged in the overall (41.4 vs. 33.2%, P value 0.06) and in the tMCS (41.6 vs. 32%, P value 0.07) groups. At multivariate Cox regression analysis, female sex was associated with higher in-hospital mortality only in the tMCS group (adjusted hazard ratio 1.59; 95% confidence interval 1.05-2.39; P value 0.03). No differences emerged in terms of MCS-related complications (28 vs. 25%, P value 0.6).
CONCLUSION: Female sex is associated with a worse in-hospital survival among cardiogenic shock patients treated with tMCS. Future research should ensure adequate female representation to clarify underlying mechanisms.
METHODS: We analyzed consecutive cardiogenic shock patients enrolled from January 2020 to November 2023 in the multicenter Altshock-2 Registry. The primary outcome was in-hospital mortality.
RESULTS: Among 692 patients [162 (23%) women, 530 (77%) men, mean age 65 (SD 14) years], cardiogenic shock was due to myocardial infarction in 50.1% and heart failure in 29.1%. Other causes were more common in females vs. males (30.5 vs. 17.8%, P value 0.03). At presentation, women had higher lactate levels [3.4 (1.7-7.3) vs. 2.6 (1.6-5.3) mmol/l, P value 0.03] and more frequent severe right ventricular dysfunction (61.8 vs. 49.6%, P value 0.02). tMCS was used in 445 (64.7%) patients without significant sex differences (P value 0.5). Intra-aortic balloon pump was the most used device (73% women vs. 82% men, P value 0.06), followed by extra corporeal membrane oxygenation (33.7 vs. 29.7%, P value 0.4) and Impella (18.8 vs. 23.5%, P value 0.3). A not-significant higher in-hospital mortality in women emerged in the overall (41.4 vs. 33.2%, P value 0.06) and in the tMCS (41.6 vs. 32%, P value 0.07) groups. At multivariate Cox regression analysis, female sex was associated with higher in-hospital mortality only in the tMCS group (adjusted hazard ratio 1.59; 95% confidence interval 1.05-2.39; P value 0.03). No differences emerged in terms of MCS-related complications (28 vs. 25%, P value 0.6).
CONCLUSION: Female sex is associated with a worse in-hospital survival among cardiogenic shock patients treated with tMCS. Future research should ensure adequate female representation to clarify underlying mechanisms.